Cargando…

The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis

BACKGROUND/AIM: N-Acetylcysteine (NAC) demonstrates applications in the prevention of exacerbation of chronic obstructive pulmonary disease (COPD). COPD is often characterized by fibrosis of the small airways. This study aims at investigating the physiological mechanisms by which NAC might mediate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lanlan, Xu, Fei, Kang, Xiuhua, Zhou, Jing, Yao, Qinqin, Lin, Yang, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414683/
https://www.ncbi.nlm.nih.gov/pubmed/34479474
http://dx.doi.org/10.1186/s10020-021-00342-y
_version_ 1783747828542078976
author Zhu, Lanlan
Xu, Fei
Kang, Xiuhua
Zhou, Jing
Yao, Qinqin
Lin, Yang
Zhang, Wei
author_facet Zhu, Lanlan
Xu, Fei
Kang, Xiuhua
Zhou, Jing
Yao, Qinqin
Lin, Yang
Zhang, Wei
author_sort Zhu, Lanlan
collection PubMed
description BACKGROUND/AIM: N-Acetylcysteine (NAC) demonstrates applications in the prevention of exacerbation of chronic obstructive pulmonary disease (COPD). COPD is often characterized by fibrosis of the small airways. This study aims at investigating the physiological mechanisms by which NAC might mediate the pulmonary fibrosis in COPD. METHODS: A total of 10 non-smokers without COPD and 10 smokers with COPD were recruited in this study, and COPD rat models were established. Cigarette smoke extract (CSE) cell models were constructed. The gain- or loss-of-function experiments were adopted to determine the expression of VWF and the extent of p38 MAPK phosphorylation, levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and immunoglobulins (IgG, IgM and IgA) in the serum of COPD rats and supernatant of alveolar epithelial cells and to detect cell invasion and migration and the ratio of CD3(+), CD4(+), CD8(+) and CD4(+)/CD8(+)T lymphocytes. RESULTS: Expression of VWF and the extent of p38 MAPK phosphorylation were increased in COPD. NAC inhibited p38 MAPK phosphorylation by reducing the VWF expression. NAC could inhibit cell migration and invasion, elevate E-cadherin expression, the ratio of CD3(+), CD4(+), CD8(+) and CD4(+)/CD8(+)T lymphocytes, and levels of IgG, IgA, and IgM, and reduce N-cadherin expression and levels of IL-6 and TNF-α in CSE cells and serum of COPD rats. NAC promoted immune response and suppressed epithelial-mesenchymal transformation (EMT) to relieve COPD-induced pulmonary fibrosis in vitro and in vivo by inhibiting the VWF/p38 MAPK axis. CONCLUSIONS: Collectively, NAC could ameliorate COPD-induced pulmonary fibrosis by promoting immune response and inhibiting EMT process via the VWF/p38 MAPK axis, therefore providing us with a potential therapeutic target for treating COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00342-y.
format Online
Article
Text
id pubmed-8414683
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84146832021-09-09 The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis Zhu, Lanlan Xu, Fei Kang, Xiuhua Zhou, Jing Yao, Qinqin Lin, Yang Zhang, Wei Mol Med Research Article BACKGROUND/AIM: N-Acetylcysteine (NAC) demonstrates applications in the prevention of exacerbation of chronic obstructive pulmonary disease (COPD). COPD is often characterized by fibrosis of the small airways. This study aims at investigating the physiological mechanisms by which NAC might mediate the pulmonary fibrosis in COPD. METHODS: A total of 10 non-smokers without COPD and 10 smokers with COPD were recruited in this study, and COPD rat models were established. Cigarette smoke extract (CSE) cell models were constructed. The gain- or loss-of-function experiments were adopted to determine the expression of VWF and the extent of p38 MAPK phosphorylation, levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and immunoglobulins (IgG, IgM and IgA) in the serum of COPD rats and supernatant of alveolar epithelial cells and to detect cell invasion and migration and the ratio of CD3(+), CD4(+), CD8(+) and CD4(+)/CD8(+)T lymphocytes. RESULTS: Expression of VWF and the extent of p38 MAPK phosphorylation were increased in COPD. NAC inhibited p38 MAPK phosphorylation by reducing the VWF expression. NAC could inhibit cell migration and invasion, elevate E-cadherin expression, the ratio of CD3(+), CD4(+), CD8(+) and CD4(+)/CD8(+)T lymphocytes, and levels of IgG, IgA, and IgM, and reduce N-cadherin expression and levels of IL-6 and TNF-α in CSE cells and serum of COPD rats. NAC promoted immune response and suppressed epithelial-mesenchymal transformation (EMT) to relieve COPD-induced pulmonary fibrosis in vitro and in vivo by inhibiting the VWF/p38 MAPK axis. CONCLUSIONS: Collectively, NAC could ameliorate COPD-induced pulmonary fibrosis by promoting immune response and inhibiting EMT process via the VWF/p38 MAPK axis, therefore providing us with a potential therapeutic target for treating COPD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00342-y. BioMed Central 2021-09-03 /pmc/articles/PMC8414683/ /pubmed/34479474 http://dx.doi.org/10.1186/s10020-021-00342-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Zhu, Lanlan
Xu, Fei
Kang, Xiuhua
Zhou, Jing
Yao, Qinqin
Lin, Yang
Zhang, Wei
The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title_full The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title_fullStr The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title_full_unstemmed The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title_short The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis
title_sort antioxidant n-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the vwf/p38 mapk axis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414683/
https://www.ncbi.nlm.nih.gov/pubmed/34479474
http://dx.doi.org/10.1186/s10020-021-00342-y
work_keys_str_mv AT zhulanlan theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT xufei theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT kangxiuhua theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT zhoujing theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT yaoqinqin theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT linyang theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT zhangwei theantioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT zhulanlan antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT xufei antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT kangxiuhua antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT zhoujing antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT yaoqinqin antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT linyang antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis
AT zhangwei antioxidantnacetylcysteinepromotesimmuneresponseandinhibitsepithelialmesenchymaltransitiontoalleviatepulmonaryfibrosisinchronicobstructivepulmonarydiseasebysuppressingthevwfp38mapkaxis